Veterinary Bone Grafts and Substitutes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Animal Type, By Material, By Application, By End User, By Region & Competition, 2021-2031F

Description

The Global Veterinary Bone Grafts and Substitutes Market is projected to expand significantly, rising from USD 272.64 Million in 2025 to USD 392.03 Million by 2031, demonstrating a 6.24% Compound Annual Growth Rate. These specialized biological or synthetic materials are crucial for bone regeneration, structural support, and repair in animals facing fractures, osseous defects, or degenerative joint conditions. Key growth drivers include the increasing incidence of orthopedic issues such as osteoarthritis and the prevalent trend of pet humanization, which encourages owners to seek advanced medical care. This demand is further boosted by a steadily growing companion animal patient base; for instance, the United States dog population reached approximately 87.3 million in 2025, according to the American Veterinary Medical Association, directly increasing the number of potential candidates for orthopedic surgeries and grafting procedures. This rising population creates a sustained need for these advanced veterinary solutions. However, the market encounters a significant hurdle in the form of high treatment expenses. The combined costs of advanced graft materials and specialized surgical expertise frequently exceed what many pet owners can afford, particularly in scenarios where pet insurance coverage remains limited. Consequently, these financial limitations often deter the selection of premium grafting options, thereby impeding broader market expansion and restricting access to advanced care primarily to more affluent segments of pet ownership. This economic barrier poses a substantial challenge to the widespread adoption of these crucial veterinary interventions.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 272.64 MIllion
Market Size 2031	USD 392.03 MIllion
CAGR 2026-2031	6.24%
Fastest Growing Segment	Autografts
Largest Market	North America

Market Driver

Significant advancements in veterinary bone graft technologies and materials are a primary catalyst for market expansion, increasingly providing more effective synthetic alternatives to traditional autografts. Innovators are actively developing bioactive synthetic substitutes and specialized implants that not only reduce surgical time but also eliminate the morbidity associated with harvesting bone from the patient's own body. The commercial success of these sophisticated technologies is underscored by recent financial reports from leading industry players; for example, Vimian Group's MedTech segment, specializing in veterinary orthopedics, returned to organic growth with a 5% increase in the third quarter of 2025, driven by the sustained adoption of its advanced surgical solutions. Concurrently, the increasing prevalence of veterinary orthopedic disorders, particularly osteoarthritis and cruciate ligament injuries, acts as another critical accelerator for the demand for grafting procedures. As the companion animal population ages, the frequency of degenerative joint diseases requiring surgical intervention has escalated, directly increasing the volume of necessary bone reconstruction surgeries. This trend is further supported by recent insurance analyses, which track the growing financial impact of these conditions. According to GlobalPETS, data from Embrace Pet Insurance revealed a significant 49% year-over-year increase in osteoarthritis claims in 2024, reflecting a substantial rise in diagnosed cases. This expanding clinical need is bolstered by a robust animal health economy, as evidenced by Zoetis reporting total revenue of $2.4 billion for the third quarter of 2025, highlighting the consistent high expenditure on companion animal care.

Market Challenge

The Global Veterinary Bone Grafts and Substitutes Market faces a substantial impediment to growth due to the elevated cost of treatment. Advanced bone grafting procedures encompass not only the price of sophisticated biological or synthetic substitutes but also significant surgical fees, hospitalization, and subsequent post-operative care. These cumulative expenses frequently position premium orthopedic interventions beyond the financial reach of a considerable proportion of pet owners. The economic burden is exacerbated by the fact that veterinary healthcare in many regions is primarily an out-of-pocket expense, with very limited financial safety nets available to mitigate these costs. This scarcity of financial support is clearly demonstrated by the limited adoption of coverage options that could otherwise alleviate these high expenses. According to the North American Pet Health Insurance Association, the pet insurance penetration rate in the United States was approximately 3.9% in 2024. This statistic indicates that the vast majority of pet owners remain financially vulnerable to the full cost of medical procedures. Consequently, when confronted with expensive orthopedic surgeries requiring bone grafts, many owners are compelled to opt for less costly, conservative management strategies, thereby directly limiting the market's revenue potential and overall adoption rate.

Market Trends

The convergence of bone grafts with orthobiologics and stem cell therapies is profoundly transforming the veterinary market, shifting treatment paradigms from passive structural repair to active biological regeneration. This trend involves integrating traditional graft materials with advanced biologics, such as mesenchymal stem cells and growth factors, to accelerate osteoinduction and improve outcomes in complex orthopedic conditions like osteoarthritis. The industry is witnessing significant investment in these "off-the-shelf" regenerative solutions, which aim to provide immediate, scalable therapeutic options without the morbidity associated with autograft harvesting. For example, Gallant Therapeutics secured $18 million in Series B financing in June 2025 to commercialize its ready-to-use allogeneic stem cell therapies, validating strong market confidence in next-generation regenerative products. Simultaneously, the integration of 3D-printing technology for patient-specific bone scaffolds is establishing a new benchmark for precision in veterinary reconstructive surgery. This technology enables the fabrication of implants that perfectly conform to the unique anatomical geometry of an animal's osseous defect, substantially reducing surgical time and enhancing mechanical stability. The adoption of additive manufacturing is rapidly scaling, progressing beyond academic prototypes to industrial-grade production facilities capable of delivering customized solutions with short lead times. As an illustration, Wimba launched a new in-house 3D printing facility in February 2025 to expand its capacity for manufacturing patient-specific veterinary orthopedic devices, directly addressing the growing demand for tailored surgical interventions.

Key Market Players

Vimian Group AB
TheraVet S.A.
Biomendex Oy
Integra LifeSciences Corporation
Progenica Therapeutics, LLC
Nutramax Laboratories Veterinary Sciences, Inc.
RITA LEIBINGER GmbH & Co. KG
AlphaLogix, LLC
VETEREGEN
BioChange

Report Scope

In this report, the Global Veterinary Bone Grafts and Substitutes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Bone Grafts and Substitutes Market, By Product

Autografts
Allografts
Xenografts
Others

Veterinary Bone Grafts and Substitutes Market, By Animal Type

Dogs
Cats
Horses
Others

Veterinary Bone Grafts and Substitutes Market, By Material

Tricalcium Phosphate (TCP)
Ceramic
Bioglass
Others

Veterinary Bone Grafts and Substitutes Market, By Application

Orthopedics
Dental
Ocular
Osteosarcoma
Others

Veterinary Bone Grafts and Substitutes Market, By End User

Veterinary Hospitals & Clinics
Others

Veterinary Bone Grafts and Substitutes Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Bone Grafts and Substitutes Market.

Available Customizations:

Global Veterinary Bone Grafts and Substitutes Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Bone Grafts and Substitutes Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Autografts, Allografts, Xenografts, Others)
- 5.2.2. By Animal Type (Dogs, Cats, Horses, Others)
- 5.2.3. By Material (Tricalcium Phosphate (TCP), Ceramic, Bioglass, Others)
- 5.2.4. By Application (Orthopedics, Dental, Ocular, Osteosarcoma, Others)
- 5.2.5. By End User (Veterinary Hospitals & Clinics, Others)
- 5.2.6. By Region
- 5.2.7. By Company (2025)
5.3. Market Map

6. North America Veterinary Bone Grafts and Substitutes Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Animal Type
- 6.2.3. By Material
- 6.2.4. By Application
- 6.2.5. By End User
- 6.2.6. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Veterinary Bone Grafts and Substitutes Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Animal Type
    - 6.3.1.2.3. By Material
    - 6.3.1.2.4. By Application
    - 6.3.1.2.5. By End User
- 6.3.2. Canada Veterinary Bone Grafts and Substitutes Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Animal Type
    - 6.3.2.2.3. By Material
    - 6.3.2.2.4. By Application
    - 6.3.2.2.5. By End User
- 6.3.3. Mexico Veterinary Bone Grafts and Substitutes Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Animal Type
    - 6.3.3.2.3. By Material
    - 6.3.3.2.4. By Application
    - 6.3.3.2.5. By End User

7. Europe Veterinary Bone Grafts and Substitutes Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Animal Type
- 7.2.3. By Material
- 7.2.4. By Application
- 7.2.5. By End User
- 7.2.6. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Veterinary Bone Grafts and Substitutes Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Animal Type
    - 7.3.1.2.3. By Material
    - 7.3.1.2.4. By Application
    - 7.3.1.2.5. By End User
- 7.3.2. France Veterinary Bone Grafts and Substitutes Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Animal Type
    - 7.3.2.2.3. By Material
    - 7.3.2.2.4. By Application
    - 7.3.2.2.5. By End User
- 7.3.3. United Kingdom Veterinary Bone Grafts and Substitutes Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Animal Type
    - 7.3.3.2.3. By Material
    - 7.3.3.2.4. By Application
    - 7.3.3.2.5. By End User
- 7.3.4. Italy Veterinary Bone Grafts and Substitutes Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Animal Type
    - 7.3.4.2.3. By Material
    - 7.3.4.2.4. By Application
    - 7.3.4.2.5. By End User
- 7.3.5. Spain Veterinary Bone Grafts and Substitutes Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Animal Type
    - 7.3.5.2.3. By Material
    - 7.3.5.2.4. By Application
    - 7.3.5.2.5. By End User

8. Asia Pacific Veterinary Bone Grafts and Substitutes Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Animal Type
- 8.2.3. By Material
- 8.2.4. By Application
- 8.2.5. By End User
- 8.2.6. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Veterinary Bone Grafts and Substitutes Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Animal Type
    - 8.3.1.2.3. By Material
    - 8.3.1.2.4. By Application
    - 8.3.1.2.5. By End User
- 8.3.2. India Veterinary Bone Grafts and Substitutes Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Animal Type
    - 8.3.2.2.3. By Material
    - 8.3.2.2.4. By Application
    - 8.3.2.2.5. By End User
- 8.3.3. Japan Veterinary Bone Grafts and Substitutes Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Animal Type
    - 8.3.3.2.3. By Material
    - 8.3.3.2.4. By Application
    - 8.3.3.2.5. By End User
- 8.3.4. South Korea Veterinary Bone Grafts and Substitutes Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Animal Type
    - 8.3.4.2.3. By Material
    - 8.3.4.2.4. By Application
    - 8.3.4.2.5. By End User
- 8.3.5. Australia Veterinary Bone Grafts and Substitutes Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Animal Type
    - 8.3.5.2.3. By Material
    - 8.3.5.2.4. By Application
    - 8.3.5.2.5. By End User

9. Middle East & Africa Veterinary Bone Grafts and Substitutes Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Animal Type
- 9.2.3. By Material
- 9.2.4. By Application
- 9.2.5. By End User
- 9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Veterinary Bone Grafts and Substitutes Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Animal Type
    - 9.3.1.2.3. By Material
    - 9.3.1.2.4. By Application
    - 9.3.1.2.5. By End User
- 9.3.2. UAE Veterinary Bone Grafts and Substitutes Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Animal Type
    - 9.3.2.2.3. By Material
    - 9.3.2.2.4. By Application
    - 9.3.2.2.5. By End User
- 9.3.3. South Africa Veterinary Bone Grafts and Substitutes Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Animal Type
    - 9.3.3.2.3. By Material
    - 9.3.3.2.4. By Application
    - 9.3.3.2.5. By End User

10. South America Veterinary Bone Grafts and Substitutes Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Animal Type
- 10.2.3. By Material
- 10.2.4. By Application
- 10.2.5. By End User
- 10.2.6. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Veterinary Bone Grafts and Substitutes Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Animal Type
    - 10.3.1.2.3. By Material
    - 10.3.1.2.4. By Application
    - 10.3.1.2.5. By End User
- 10.3.2. Colombia Veterinary Bone Grafts and Substitutes Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Animal Type
    - 10.3.2.2.3. By Material
    - 10.3.2.2.4. By Application
    - 10.3.2.2.5. By End User
- 10.3.3. Argentina Veterinary Bone Grafts and Substitutes Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Animal Type
    - 10.3.3.2.3. By Material
    - 10.3.3.2.4. By Application
    - 10.3.3.2.5. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Veterinary Bone Grafts and Substitutes Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Vimian Group AB
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. TheraVet S.A.
15.3. Biomendex Oy
15.4. Integra LifeSciences Corporation
15.5. Progenica Therapeutics, LLC
15.6. Nutramax Laboratories Veterinary Sciences, Inc.
15.7. RITA LEIBINGER GmbH & Co. KG
15.8. AlphaLogix, LLC
15.9. VETEREGEN
15.10. BioChange